Stem cell dose may boost immune recovery in aggressive lymphoma
NCT ID NCT02570542
First seen Dec 16, 2025 · Last updated Apr 28, 2026 · Updated 15 times
Summary
This study looks at whether the number of stem cells given during a transplant helps the immune system recover faster in people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). About 59 adults who have already had some chemotherapy will receive high-dose therapy followed by a stem cell transplant. The goal is to see if a higher stem cell dose leads to better cancer control and fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University
New York, New York, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up Only)
Basking Ridge, New Jersey, United States
-
Memorial Sloan Kettering Bergen (Consent and Follow Up Only)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack (Consent and Follow-up Only)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth (Consent and Follow up Only)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (Consent and Follow up Only)
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester
Harrison, New York, 10604, United States
-
Northwell Health (Data collection only)
Manhasset, New York, 11030, United States
-
Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
Texas Transplant Institute
San Antonio, Texas, 78229, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198-7680, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.